Basic Information
Nilo Therapeutics is a biotechnology company dedicated to developing a new class of drugs that restore disease immune homeostasis by leveraging neural circuits. By targeting the master regulator brain-body circuits that centrally control systemic inflammation, Nilo has pioneered a differentiated approach to immunomodulation, with the potential to treat a wide range of autoimmune and inflammatory diseases, addressing significant unmet therapeutic needs.
Nilo Therapeutics
NewYork,NewYork,United States of America
15~50 people
January 01, 2024
--

